Vertex Pharmaceuticals Incorporated (VRTX) Financials
VRTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 27.4 billion | 7.2 billion |
| March 31, 2026 | 26.5 billion | 7.1 billion |
| Dec. 31, 2025 | 26.1 billion | 7.5 billion |
| Sept. 30, 2025 | 24.9 billion | 7.5 billion |
VRTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 1.0 billion | 170.2 million |
| March 31, 2026 | 1.3 billion | 166.4 million |
| Dec. 31, 2025 | 348.6 million | 157.6 million |
| Sept. 30, 2025 | 1.1 billion | 194.9 million |
VRTX Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | 1.1 billion |
| March 31, 2026 | 1.0 billion |
| Dec. 31, 2025 | 1.2 billion |
| Sept. 30, 2025 | 1.1 billion |
VRTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 7.9 billion | - | 2.0 billion |
| March 31, 2026 | 7.2 billion | - | 2.0 billion |
| Dec. 31, 2025 | 6.6 billion | 1.8 billion | 2.0 billion |
| Sept. 30, 2025 | 6.3 billion | - | 1.8 billion |
VRTX Shares Outstanding
VRTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 112.2 million | 993.8 million | 582.2 million | - |
| March 31, 2026 | 133.4 million | 961.6 million | 493.7 million | - |
| Dec. 31, 2025 | 149.4 million | 973.7 million | 487.0 million | - |
| Sept. 30, 2025 | 101.8 million | 1.0 billion | 445.1 million | - |
VRTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 3.3 billion | 489.2 million |
| March 31, 2026 | 3.0 billion | 392.8 million |
| Dec. 31, 2025 | 3.2 billion | 466.0 million |
| Sept. 30, 2025 | 3.1 billion | 414.8 million |
VRTX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
VRTX
Price: $510.62
52 week price:
Payout Ratio Range:
Earnings Per Share: 17.16 USD
P/E Ratio: 28.91
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Ebitda: 142.2 millionMarket Capitalization: 127.5 billion